AI Meets Pharma: Mankind Leverages OpenAI to Build a Smarter, Faster Enterprise

Mumbai: Mankind Pharma, India’s fourth-largest pharmaceutical company, has announced a strategic collaboration with OpenAI to integrate advanced artificial intelligence across its operations. As one of the first Indian pharma companies to adopt AI at scale, Mankind aims to accelerate innovation, enhance operational efficiency, and deliver greater value to customers, healthcare professionals, and the broader ecosystem.

The company will deploy OpenAI Enterprise across key functions including field force enablement, digital marketing, research and development (R&D), manufacturing, and medical affairs. By leveraging OpenAI’s latest models, including GPT-5, Mankind seeks to transform data into actionable insights, streamline communication, and optimize complex workflows from discovery to delivery.

Commenting on the partnership, Arjun Juneja, Chief Operating Officer, Mankind Pharma Ltd., said, “Working with OpenAI is a pivotal step in building the pharma organization of the future. This is not just about automation—it’s about creating a more responsive, intelligent, and future-ready enterprise. We’re excited to lead this shift in Indian pharma and set new benchmarks for operational excellence and long-term value creation.”

The integration will enhance several areas of Mankind Pharma’s operations:

• Smarter decision-making through GPT-powered dashboards offering real-time insights across R&D, supply chain, and commercial functions
• Faster compliant communication with automated, multilingual content for healthcare professionals and patients
• Function-specific AI agents to boost efficiency in Sales & Marketing, R&D, and HR
• Advanced clinical intelligence via streamlined literature reviews and real-time genomic data analysis
• Manufacturing excellence through AI-driven anomaly detection and corrective action recommendations

Since July 2025, Mankind has deployed customized GPTs across its workforce, notably improving Sales and Marketing effectiveness. These tools have enhanced multilingual messaging, demand planning, procurement, and commercial operations. Real-time field force performance tracking and proactive clinical insights have freed leadership to focus on strategic growth.

Custom GPTs allow organizations to build tailored AI assistants with defined tone, personality, and specialized knowledge, integrating proprietary data and workflows without requiring advanced coding. This flexibility has enabled Mankind to create industry-specific solutions that align with its operational goals.

Oliver Jay, Managing Director, International at OpenAI, said, “Mankind Pharma’s company-wide adoption of ChatGPT Enterprise shows the practical role AI can play in regulated industries. We look forward to working with them to explore responsible and impactful applications of AI across healthcare.”